The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback